Roivant Sciences Ltd.

ROIVNasdaq· Pharmaceutical Preparations

Price History

Revenue

$8.3M

▼ 71.6% YoY

Net Income

-$299.8M

▼ 74.3% YoY

EPS

$-0.54

▼ 125.0% YoY

Cash

$1.4B

▼ 47.7% YoY

FY 2026 · As of 2026-03-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.